Skip to main content
. 2021 Aug 27;11(9):850. doi: 10.3390/jpm11090850

Table 3.

Studies reporting PROs from validated PROM instruments following genetic testing for breast and ovarian cancer syndrome or Lynch syndrome.

Study ID Genetic Disease PROM Instrument Used
Beri et al. (2019) [21] Breast and ovarian cancer - Cancer Genetics Knowledge Scale
- State-Trait Anxiety Inventory
- Hospital Anxiety and Depression Scale
- Impact of Event Scale
- Multidimensional Impact of Cancer Risk Assessment
Croyle et al. (1997) Breast and ovarian cancer - State-Trait Anxiety Inventory
- Impact of Event Scale
deWit et al. (1998) [18] Breast and ovarian cancer - Impact of Event Scale
Esplen et al. (2015) [23] Lynch syndrome - Center for Epidemiologic Studies for Depression Scale
- State-Trait Anxiety Inventory
- Impact of Event Scale
- Perception of Lifetime Risk for Colorectal Cancer
- Colonoscopy Screening
- Ways of Coping Questionnaire
- Social Support Questionnaire
- Quality of Life Index
- Demographic and Medical Information Questionnaire
Hughes Halbert et al. (2011) [25] Breast and ovarian cancer - Multidimensional Impact of Cancer Risk Assessment
Lerman et al. (1996) [27] Breast and ovarian cancer - Center for Epidemiologic Studies for Depression Scale
- Medical Outcomes Study
Lerman et al. (1998) [28] Breast and ovarian cancer - Center for Epidemiologic Studies for Depression Scale
- Intrusion Subscale of the Revised Impact of Event Scale
Manchanda et al. (2019) [32] Breast and ovarian cancer - Hospital Anxiety and Depression Scale
- Health Anxiety Inventory
- Multidimensional Impact of Cancer Risk Assessment
- SF12 questionnaire (Physical Health Component Scale and Mental Health Component Scale)
Meiser et al. (2018) [33] Breast and ovarian cancer - Impact of Event Scale
- Hospital Anxiety and Depression Scale
- Decision Regret Scale (genetic testing choice and surgery choice)
Mella et al. (2017) [34] Breast and ovarian cancer - Hospital Anxiety and Depression Scale
- Profile of Mood States
- Emotional Thermometers (ad hoc instrument)
Underhill-Blazey et al. (2020) [37] Breast, ovarian, and endometrial/uterine cancer - Multidimensional Impact of Cancer Risk Assessment
Voorwinden et al. (2012) [38] Lynch syndrome
Breast and ovarian cancer
- General Health Questionnaire-12
- Cancer Worry Scale